MedPath
NMPA Approval

Compound Cerebroprotein Hydrolysate Tablets

国药准字H34022261

January 22, 2021

国药准字H34022261

Drug Information

复方脑蛋白水解物片

强身

片剂

复方

化学药品

January 22, 2021

Company Information

Applicant Company

阜阳市颍上工业开发区

Manufacturing Company

阜阳市颍上工业开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方脑蛋白水解物片 - NMPA 批准文号 | MedPath